NCT02825875View on ClinicalTrials.gov

Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 8, 2016

Primary Completion Date

April 30, 2020

Study Completion Date

April 30, 2020

Conditions
Prostate Cancer
Interventions
DRUG

18F DCFPyL- Radiopharmaceutica

Trial Locations (1)

21287

Johns Hopkins University, Baltimore

All Listed Sponsors
collaborator

Progenics Pharmaceuticals, Inc.

INDUSTRY

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT02825875 - Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer | Biotech Hunter | Biotech Hunter